IFPA and New Jersey RICO PIP-Fraud Claims Are Not Subject to AICRA PIP Arbitration

1. Introduction

Allstate New Jersey Insurance Company v. Carteret Comprehensive Medical Care, P.C. addresses a recurring no-fault insurance dispute: whether an insurer’s affirmative civil claims alleging a coordinated scheme to obtain personal injury protection (PIP) payments through fraud must be sent to the PIP arbitration forum created by the Automobile Insurance Cost Reduction Act (AICRA).

Parties. Six related Allstate insurers (collectively, “Allstate”) sued multiple medical practices and physicians (collectively, “defendants”), alleging a conspiracy that obtained more than $1.7 million in PIP payments through fraudulent and misleading medical claims.

Core issue. Are insurer claims under the Insurance Fraud Prevention Act (the Fraud Act) and the New Jersey Anti-Racketeering Act (RICO) “dispute[s] regarding the recovery of ... benefits” that must be arbitrated under AICRA’s PIP arbitration provision, N.J.S.A. 39:6A-5.1(a)?

2. Summary of the Opinion

The Supreme Court of New Jersey issued a short per curiam decision affirming the Appellate Division “substantially for the reasons expressed” in Judge Gilson’s published opinion, Allstate N.J. Ins. Co. v. Carteret Comprehensive Med. Care, PC, 480 N.J. Super. 566 (App. Div. 2025).

Holding (as adopted by the Supreme Court). Claims brought by an insurer under the Fraud Act or RICO do not fall within the ambit of AICRA PIP arbitration. Those claims may proceed in the Law Division, with the associated procedural tools and the right to a jury trial.

3. Analysis

A. Precedents Cited

  • Allstate N.J. Ins. Co. v. Carteret Comprehensive Med. Care, PC, 480 N.J. Super. 566 (App. Div. 2025)
    Role in the Supreme Court decision: This Appellate Division opinion is the operative reasoning. The Supreme Court affirmed “substantially for the reasons expressed” there, thereby elevating its statutory construction and forum-allocation analysis to binding New Jersey precedent.
    Key contributions: It (1) read AICRA’s arbitration text in context, including the “not necessarily exhaustive” list of disputes in N.J.S.A. 39:6A-5.1(c); (2) compared the remedial and procedural design of PIP arbitration to the remedies authorized by the Fraud Act and RICO; and (3) harmonized the statutes by channeling routine PIP-payment disputes to arbitration while reserving complex fraud-and-racketeering litigation to court.
  • Gov't Emps. Ins. Co. v. Mt. Prospect Chiropractic Ctr., 98 F.4th 463 (3d. Cir. 2024)
    How it was treated: The Appellate Division acknowledged that the Third Circuit “recently ... held that claims under the Fraud Act are arbitrable under AICRA,” but expressly disagreed and emphasized it was interpreting New Jersey law and therefore was not bound by that federal appellate prediction.
    Doctrinal significance after this case: With the New Jersey Supreme Court now affirming the Appellate Division’s contrary reading, the authoritative construction of New Jersey statutes is the state high court’s: Fraud Act and RICO claims are outside AICRA PIP arbitration.

B. Legal Reasoning

Although the Supreme Court’s opinion is brief, its adoption of the Appellate Division’s reasoning establishes a clear interpretive method and rule:

  1. Text and statutory context control, not labels. AICRA allows arbitration of “[a]ny dispute regarding the recovery of ... benefits provided under [PIP] coverage ...” arising from automobile use. But the Appellate Division treated that phrase as describing a category of PIP-benefit recovery disputes—not an all-purpose mandate that every controversy touching PIP payments must be arbitrated, regardless of the cause of action and remedies sought.
  2. Harmonization of related statutes. The court sought to “harmonize” AICRA with the Fraud Act and RICO by construing each in light of its legislative goals: AICRA’s “streamlined and specialized” arbitration mechanism is designed for limited, efficient benefit-payment disputes, while the Fraud Act and RICO are enforcement statutes designed to deter and remedy fraud schemes with robust damages and litigation tools.
  3. Remedies and procedure matter to forum selection. The Appellate Division emphasized the mismatch between:
    • Fraud Act remedies: compensatory damages, investigative expenses, costs, attorneys’ fees, and treble damages where a pattern is shown; and
    • RICO remedies: a civil action in “court” to recover damages and seek injunctive relief.
    Against that, PIP arbitration was described as lacking authority for equitable relief and raising “serious questions” about broad discovery, joinder of third parties, and the ability to award compensatory/treble damages or attorneys’ fees to an insurer. That mismatch supported the conclusion that the Legislature did not intend AICRA arbitration to displace court adjudication of complex fraud/racketeering claims.
  4. Decision Point Review Plans are not broader than the statute. Defendants argued arbitration was independently required by Allstate’s Decision Point Review Plans. The Appellate Division rejected that argument as a matter of state law: arbitration provisions “mandated by regulations promulgated under AICRA” cannot exceed the scope of AICRA’s statutory PIP arbitration itself.
  5. Constitutional avoidance (jury-trial concern). The Appellate Division noted Allstate’s argument that forcing Fraud Act and RICO claims into arbitration would impair the right to a jury trial. By construing AICRA not to compel arbitration of those claims, the court avoided having to decide that constitutional question. The Supreme Court’s affirmance preserves that avoidance-based resolution.

C. Impact

  • Clear allocation of forums. Routine disputes about payment of PIP benefits remain within AICRA’s streamlined arbitration system, but insurer-initiated litigation alleging fraudulent schemes under the Fraud Act or RICO proceeds in court.
  • Enhanced anti-fraud enforcement in practice. Insurers may pursue Fraud Act and RICO toolkits—broader discovery, multi-party joinder where appropriate, damages theories including trebling, fee shifting (where authorized), and equitable/injunctive relief (especially under RICO)—without being constrained by the narrower arbitral forum.
  • Reduced strategic “arbitration shielding.” Medical-provider defendants facing fraud-scheme allegations cannot compel transfer to PIP arbitration simply because the alleged fraud involves PIP billing.
  • Clarification of New Jersey law vis-à-vis federal interpretations. The decision resolves the state-law question contrary to the Third Circuit’s approach in Gov't Emps. Ins. Co. v. Mt. Prospect Chiropractic Ctr., anchoring the controlling interpretation for New Jersey statutory claims.

4. Complex Concepts Simplified

  • PIP (Personal Injury Protection). No-fault benefits that pay certain medical expenses and related costs after an auto accident, regardless of who caused it.
  • AICRA PIP arbitration. A specialized, streamlined dispute-resolution process intended primarily for benefit-payment disputes (e.g., whether treatment is reimbursable, the amount, timeliness).
  • Insurance Fraud Prevention Act (Fraud Act). A statute aimed at deterring and compensating for insurance fraud; it authorizes significant monetary remedies, including attorneys’ fees and treble damages in specified circumstances.
  • New Jersey RICO. A statute targeting patterns of racketeering activity; it contemplates court actions for damages and can include injunctive (stop-order) relief.
  • Equitable relief / injunctive relief. Non-monetary court orders (e.g., to stop conduct, freeze assets, enforce compliance). The Appellate Division noted PIP arbitrators lack authority to grant such relief.
  • Constitutional avoidance. A principle of interpretation: if a statute can reasonably be read in a way that avoids a constitutional conflict (here, jury-trial concerns), courts prefer that reading.

5. Conclusion

This decision establishes that AICRA’s PIP arbitration mandate does not extend to insurer affirmative claims alleging insurance-fraud schemes under the Fraud Act or New Jersey RICO, even when the alleged misconduct involves PIP billing. By affirming Allstate N.J. Ins. Co. v. Carteret Comprehensive Med. Care, PC, the Supreme Court confirms a practical statutory boundary: PIP arbitration remains a streamlined forum for benefit-payment disputes, while complex fraud and racketeering claims—with their broader remedies, procedural demands, and jury-trial implications—belong in court.